Omnipod is currently available in 24 countries worldwide. Omnipod DASH continues to be the leading insulin pump, with an indication for use in the Type 2 market.

Insulet has begun a voluntary recall of the remote-control devices used with its Omnipod Dash insulin pumps.

The Omnipod DASH System, which received FDA clearance in June 2018, is the only DTSec and ISO 27001 certified insulin pump for cyber and information security and safety. About Insulet Corporation: ...

Insulet attained several landmarks with regard to extending Omnipod’s market access. In the third quarter, the company successfully broadened the Omnipod DASH coverage for commercial, Medicare ...

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod.

Insulet plans to launch the Omnipod DASH System throughout Canada on a province-by-province basis throughout 2021 to coincide with reimbursement by provincial health programs.

Insulet’s Omnipod DASH System provides users with a simple and effective solution that fits easily into their daily lives by eliminating the burden of syringes, pens and tubes and 97% 1 of users ...

Insulet has issued an alert for a data breach that may have compromised the health data of thousands of users of its Omnipod Dash insulin pumps.